impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

One year in review

 

Clinical aspects of psoriatic arthritis: one year in review 2024

1, 2, 3, 4, 5, 6

 

  1. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  2. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  3. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  4. Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy.
  5. Rheumatology Unit, SOC Reumatologia, USL Toscana Centro, Florence, Italy.
  6. Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana (AOUP), Pisa, Italy. 81clinda@gmail.com

CER18548
2025 Vol.43, N°1
PI 0004, PF 0013
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 39846367 [PubMed]

Received: 17/01/2025
Accepted : 22/01/2025
In Press: 23/01/2025
Published: 23/01/2025

Abstract

Psoriatic arthritis is a very pleomorphic inflammatory disease characterised by its association with psoriasis and the development of a wide spectrum of comorbidities that can impact patients’ prognosis and quality of life. In recent years, several new drugs have been developed, showing significant efficacy in alleviating symptoms and signs, while maintaining a generally favourable safety profile. Despite these advancements, the management of PsA remains potentially suboptimal. Indeed, a percentage of patients do not respond to therapies, or they may improve only in limited outcomes, resulting in a challenge for the management of the burden of disease. In this paper we reviewed the literature on PsA from January 1st 2022 to July 1st 2024.

DOI: https://doi.org/10.55563/clinexprheumatol/7gug1a

Rheumatology Article